The effectiveness of long-acting penicillin (penidur) in preventing recurrences of dermatolymphangioadenitis(DLA) and controlling skin, deep tissues, and lymph bacterial flora in patients with "filarial" lymphedema.
Identifieur interne : 001F69 ( Ncbi/Checkpoint ); précédent : 001F68; suivant : 001F70The effectiveness of long-acting penicillin (penidur) in preventing recurrences of dermatolymphangioadenitis(DLA) and controlling skin, deep tissues, and lymph bacterial flora in patients with "filarial" lymphedema.
Auteurs : W L Olszewski [Pologne] ; S. Jamal ; G. Manokaran ; F M Tripathi ; M. Zaleska ; E. StelmachSource :
- Lymphology [ 0024-7766 ] ; 2005.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Antibactériens (administration et posologie), Antibactériens (usage thérapeutique), Bactéries (), Bactéries (isolement et purification), Benzathine benzylpénicilline (administration et posologie), Benzathine benzylpénicilline (usage thérapeutique), Femelle, Humains, Inde, Jambe, Liquides biologiques (), Liquides biologiques (microbiologie), Lymphadénite (), Lymphadénite (microbiologie), Lymphadénite (traitement médicamenteux), Lymphangite (), Lymphangite (microbiologie), Lymphangite (traitement médicamenteux), Lymphe (), Lymphe (microbiologie), Lymphoedème (), Lymphoedème (microbiologie), Lymphoedème (traitement médicamenteux), Mâle, Noeuds lymphatiques (), Noeuds lymphatiques (microbiologie), Peau (), Peau (microbiologie), Prévention secondaire, Sujet âgé, Études de cohortes, Études rétrospectives.
- MESH :
- administration et posologie : Antibactériens, Benzathine benzylpénicilline.
- isolement et purification : Bactéries.
- microbiologie : Liquides biologiques, Lymphadénite, Lymphangite, Lymphe, Lymphoedème, Noeuds lymphatiques, Peau.
- traitement médicamenteux : Lymphadénite, Lymphangite, Lymphoedème.
- usage thérapeutique : Antibactériens, Benzathine benzylpénicilline.
- Adulte, Adulte d'âge moyen, Bactéries, Femelle, Humains, Inde, Jambe, Liquides biologiques, Lymphadénite, Lymphangite, Lymphe, Lymphoedème, Mâle, Noeuds lymphatiques, Peau, Prévention secondaire, Sujet âgé, Études de cohortes, Études rétrospectives.
- Wicri :
- geographic : Inde.
English descriptors
- KwdEn :
- Adult, Aged, Anti-Bacterial Agents (administration & dosage), Anti-Bacterial Agents (therapeutic use), Bacteria (drug effects), Bacteria (isolation & purification), Body Fluids (drug effects), Body Fluids (microbiology), Cohort Studies, Female, Humans, India, Leg, Lymph (drug effects), Lymph (microbiology), Lymph Nodes (drug effects), Lymph Nodes (microbiology), Lymphadenitis (drug therapy), Lymphadenitis (microbiology), Lymphadenitis (prevention & control), Lymphangitis (drug therapy), Lymphangitis (microbiology), Lymphangitis (prevention & control), Lymphedema (drug therapy), Lymphedema (microbiology), Lymphedema (prevention & control), Male, Middle Aged, Penicillin G Benzathine (administration & dosage), Penicillin G Benzathine (therapeutic use), Retrospective Studies, Secondary Prevention, Skin (drug effects), Skin (microbiology).
- MESH :
- chemical , administration & dosage : Anti-Bacterial Agents, Penicillin G Benzathine.
- chemical , therapeutic use : Anti-Bacterial Agents, Penicillin G Benzathine.
- geographic : India.
- drug effects : Bacteria, Body Fluids, Lymph, Lymph Nodes, Skin.
- drug therapy : Lymphadenitis, Lymphangitis, Lymphedema.
- isolation & purification : Bacteria.
- microbiology : Body Fluids, Lymph, Lymph Nodes, Lymphadenitis, Lymphangitis, Lymphedema, Skin.
- prevention & control : Lymphadenitis, Lymphangitis, Lymphedema.
- Adult, Aged, Cohort Studies, Female, Humans, Leg, Male, Middle Aged, Retrospective Studies, Secondary Prevention.
Abstract
Dermatolymphangioadenitis (DLA) is a common and serious complication of so-called "filarial" and bacterial non-filarial lymphedema of the limb, affecting skin, lymphatics and lymph nodes. In our previous studies, we demonstrated that more than 60% of patients revealed presence of bacterial isolates in deep tissues, tissue fluid and lymph from the lymphedematous limbs. The question remained open whether elimination or suppression of bacteria dwelling in lymphedematous tissues by administration of low doses of penicillin for long time periods would prevent recurrence of DLA attacks. In this study, we retrospectively evaluated a self/community-selected group of patients with lymphedema of the lower limbs with respect to the efficacy of long-acting penicillin in preventing episodes of DLA. There were no microfilariae or anti-filarial antibodies detected in the investigated group. The questions we asked were: (a) how effective is the benzathine penicillin in preventing recurrences of DLA attacks and (b) how does its long-term administration influence the bacterial spectrum of leg skin, deep tissues, lymph and lymph nodes and sensitivity to antibiotics. Two randomly selected groups of patients, receiving and not receiving penicillin during the same period of time, were compared. Evidently lower recurrence rate of DLA was observed in the treated group (p < 0.002). There was increased prevalence of cocci and gram-positive bacilli with a concomitant decrease of gram-negative bacilli on the foot and calf skin surface. Simultaneously, decreased prevalence of gram-positive cocci and gram-negative bacilli isolates in limb deep tissues and lymph was seen. No resistance to penicillin and other tested antibiotics developed in isolates from the skin surface, deep tissues and lymph. We conclude that long-lasting penicillin is effective in preventing recurrent DLA attacks.
PubMed: 16184816
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003B92
- to stream PubMed, to step Curation: 003B92
- to stream PubMed, to step Checkpoint: 003B92
- to stream Ncbi, to step Merge: 001F69
- to stream Ncbi, to step Curation: 001F69
Links to Exploration step
pubmed:16184816Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The effectiveness of long-acting penicillin (penidur) in preventing recurrences of dermatolymphangioadenitis(DLA) and controlling skin, deep tissues, and lymph bacterial flora in patients with "filarial" lymphedema.</title><author><name sortKey="Olszewski, W L" sort="Olszewski, W L" uniqKey="Olszewski W" first="W L" last="Olszewski">W L Olszewski</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgical Research & Transplantology, Medical Research Center, Polish Academy of Sciences, Warsaw, Poland. wlo@cmdik.pan.pl</nlm:affiliation><country xml:lang="fr">Pologne</country><wicri:regionArea>Department of Surgical Research & Transplantology, Medical Research Center, Polish Academy of Sciences, Warsaw</wicri:regionArea><wicri:noRegion>Warsaw</wicri:noRegion></affiliation></author><author><name sortKey="Jamal, S" sort="Jamal, S" uniqKey="Jamal S" first="S" last="Jamal">S. Jamal</name></author><author><name sortKey="Manokaran, G" sort="Manokaran, G" uniqKey="Manokaran G" first="G" last="Manokaran">G. Manokaran</name></author><author><name sortKey="Tripathi, F M" sort="Tripathi, F M" uniqKey="Tripathi F" first="F M" last="Tripathi">F M Tripathi</name></author><author><name sortKey="Zaleska, M" sort="Zaleska, M" uniqKey="Zaleska M" first="M" last="Zaleska">M. Zaleska</name></author><author><name sortKey="Stelmach, E" sort="Stelmach, E" uniqKey="Stelmach E" first="E" last="Stelmach">E. Stelmach</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:16184816</idno><idno type="pmid">16184816</idno><idno type="wicri:Area/PubMed/Corpus">003B92</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003B92</idno><idno type="wicri:Area/PubMed/Curation">003B92</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003B92</idno><idno type="wicri:Area/PubMed/Checkpoint">003B92</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003B92</idno><idno type="wicri:Area/Ncbi/Merge">001F69</idno><idno type="wicri:Area/Ncbi/Curation">001F69</idno><idno type="wicri:Area/Ncbi/Checkpoint">001F69</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The effectiveness of long-acting penicillin (penidur) in preventing recurrences of dermatolymphangioadenitis(DLA) and controlling skin, deep tissues, and lymph bacterial flora in patients with "filarial" lymphedema.</title><author><name sortKey="Olszewski, W L" sort="Olszewski, W L" uniqKey="Olszewski W" first="W L" last="Olszewski">W L Olszewski</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgical Research & Transplantology, Medical Research Center, Polish Academy of Sciences, Warsaw, Poland. wlo@cmdik.pan.pl</nlm:affiliation><country xml:lang="fr">Pologne</country><wicri:regionArea>Department of Surgical Research & Transplantology, Medical Research Center, Polish Academy of Sciences, Warsaw</wicri:regionArea><wicri:noRegion>Warsaw</wicri:noRegion></affiliation></author><author><name sortKey="Jamal, S" sort="Jamal, S" uniqKey="Jamal S" first="S" last="Jamal">S. Jamal</name></author><author><name sortKey="Manokaran, G" sort="Manokaran, G" uniqKey="Manokaran G" first="G" last="Manokaran">G. Manokaran</name></author><author><name sortKey="Tripathi, F M" sort="Tripathi, F M" uniqKey="Tripathi F" first="F M" last="Tripathi">F M Tripathi</name></author><author><name sortKey="Zaleska, M" sort="Zaleska, M" uniqKey="Zaleska M" first="M" last="Zaleska">M. Zaleska</name></author><author><name sortKey="Stelmach, E" sort="Stelmach, E" uniqKey="Stelmach E" first="E" last="Stelmach">E. Stelmach</name></author></analytic><series><title level="j">Lymphology</title><idno type="ISSN">0024-7766</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Anti-Bacterial Agents (administration & dosage)</term><term>Anti-Bacterial Agents (therapeutic use)</term><term>Bacteria (drug effects)</term><term>Bacteria (isolation & purification)</term><term>Body Fluids (drug effects)</term><term>Body Fluids (microbiology)</term><term>Cohort Studies</term><term>Female</term><term>Humans</term><term>India</term><term>Leg</term><term>Lymph (drug effects)</term><term>Lymph (microbiology)</term><term>Lymph Nodes (drug effects)</term><term>Lymph Nodes (microbiology)</term><term>Lymphadenitis (drug therapy)</term><term>Lymphadenitis (microbiology)</term><term>Lymphadenitis (prevention & control)</term><term>Lymphangitis (drug therapy)</term><term>Lymphangitis (microbiology)</term><term>Lymphangitis (prevention & control)</term><term>Lymphedema (drug therapy)</term><term>Lymphedema (microbiology)</term><term>Lymphedema (prevention & control)</term><term>Male</term><term>Middle Aged</term><term>Penicillin G Benzathine (administration & dosage)</term><term>Penicillin G Benzathine (therapeutic use)</term><term>Retrospective Studies</term><term>Secondary Prevention</term><term>Skin (drug effects)</term><term>Skin (microbiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Antibactériens (administration et posologie)</term><term>Antibactériens (usage thérapeutique)</term><term>Bactéries ()</term><term>Bactéries (isolement et purification)</term><term>Benzathine benzylpénicilline (administration et posologie)</term><term>Benzathine benzylpénicilline (usage thérapeutique)</term><term>Femelle</term><term>Humains</term><term>Inde</term><term>Jambe</term><term>Liquides biologiques ()</term><term>Liquides biologiques (microbiologie)</term><term>Lymphadénite ()</term><term>Lymphadénite (microbiologie)</term><term>Lymphadénite (traitement médicamenteux)</term><term>Lymphangite ()</term><term>Lymphangite (microbiologie)</term><term>Lymphangite (traitement médicamenteux)</term><term>Lymphe ()</term><term>Lymphe (microbiologie)</term><term>Lymphoedème ()</term><term>Lymphoedème (microbiologie)</term><term>Lymphoedème (traitement médicamenteux)</term><term>Mâle</term><term>Noeuds lymphatiques ()</term><term>Noeuds lymphatiques (microbiologie)</term><term>Peau ()</term><term>Peau (microbiologie)</term><term>Prévention secondaire</term><term>Sujet âgé</term><term>Études de cohortes</term><term>Études rétrospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-Bacterial Agents</term><term>Penicillin G Benzathine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term><term>Penicillin G Benzathine</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>India</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antibactériens</term><term>Benzathine benzylpénicilline</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Bacteria</term><term>Body Fluids</term><term>Lymph</term><term>Lymph Nodes</term><term>Skin</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Lymphadenitis</term><term>Lymphangitis</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Bacteria</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Bactéries</term></keywords><keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Liquides biologiques</term><term>Lymphadénite</term><term>Lymphangite</term><term>Lymphe</term><term>Lymphoedème</term><term>Noeuds lymphatiques</term><term>Peau</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Body Fluids</term><term>Lymph</term><term>Lymph Nodes</term><term>Lymphadenitis</term><term>Lymphangitis</term><term>Lymphedema</term><term>Skin</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Lymphadenitis</term><term>Lymphangitis</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Lymphadénite</term><term>Lymphangite</term><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antibactériens</term><term>Benzathine benzylpénicilline</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Cohort Studies</term><term>Female</term><term>Humans</term><term>Leg</term><term>Male</term><term>Middle Aged</term><term>Retrospective Studies</term><term>Secondary Prevention</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Bactéries</term><term>Femelle</term><term>Humains</term><term>Inde</term><term>Jambe</term><term>Liquides biologiques</term><term>Lymphadénite</term><term>Lymphangite</term><term>Lymphe</term><term>Lymphoedème</term><term>Mâle</term><term>Noeuds lymphatiques</term><term>Peau</term><term>Prévention secondaire</term><term>Sujet âgé</term><term>Études de cohortes</term><term>Études rétrospectives</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Inde</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Dermatolymphangioadenitis (DLA) is a common and serious complication of so-called "filarial" and bacterial non-filarial lymphedema of the limb, affecting skin, lymphatics and lymph nodes. In our previous studies, we demonstrated that more than 60% of patients revealed presence of bacterial isolates in deep tissues, tissue fluid and lymph from the lymphedematous limbs. The question remained open whether elimination or suppression of bacteria dwelling in lymphedematous tissues by administration of low doses of penicillin for long time periods would prevent recurrence of DLA attacks. In this study, we retrospectively evaluated a self/community-selected group of patients with lymphedema of the lower limbs with respect to the efficacy of long-acting penicillin in preventing episodes of DLA. There were no microfilariae or anti-filarial antibodies detected in the investigated group. The questions we asked were: (a) how effective is the benzathine penicillin in preventing recurrences of DLA attacks and (b) how does its long-term administration influence the bacterial spectrum of leg skin, deep tissues, lymph and lymph nodes and sensitivity to antibiotics. Two randomly selected groups of patients, receiving and not receiving penicillin during the same period of time, were compared. Evidently lower recurrence rate of DLA was observed in the treated group (p < 0.002). There was increased prevalence of cocci and gram-positive bacilli with a concomitant decrease of gram-negative bacilli on the foot and calf skin surface. Simultaneously, decreased prevalence of gram-positive cocci and gram-negative bacilli isolates in limb deep tissues and lymph was seen. No resistance to penicillin and other tested antibiotics developed in isolates from the skin surface, deep tissues and lymph. We conclude that long-lasting penicillin is effective in preventing recurrent DLA attacks.</div></front></TEI><affiliations><list><country><li>Pologne</li></country></list><tree><noCountry><name sortKey="Jamal, S" sort="Jamal, S" uniqKey="Jamal S" first="S" last="Jamal">S. Jamal</name><name sortKey="Manokaran, G" sort="Manokaran, G" uniqKey="Manokaran G" first="G" last="Manokaran">G. Manokaran</name><name sortKey="Stelmach, E" sort="Stelmach, E" uniqKey="Stelmach E" first="E" last="Stelmach">E. Stelmach</name><name sortKey="Tripathi, F M" sort="Tripathi, F M" uniqKey="Tripathi F" first="F M" last="Tripathi">F M Tripathi</name><name sortKey="Zaleska, M" sort="Zaleska, M" uniqKey="Zaleska M" first="M" last="Zaleska">M. Zaleska</name></noCountry><country name="Pologne"><noRegion><name sortKey="Olszewski, W L" sort="Olszewski, W L" uniqKey="Olszewski W" first="W L" last="Olszewski">W L Olszewski</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F69 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 001F69 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Checkpoint
|type= RBID
|clé= pubmed:16184816
|texte= The effectiveness of long-acting penicillin (penidur) in preventing recurrences of dermatolymphangioadenitis(DLA) and controlling skin, deep tissues, and lymph bacterial flora in patients with "filarial" lymphedema.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:16184816" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |